Detalles de la búsqueda
1.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Ann Hematol
; 98(2): 321-330, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446802
2.
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
Am J Hematol
; 90(5): 429-33, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25683327
3.
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.
Clinicoecon Outcomes Res
; 13: 263-277, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33911887
4.
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
Cancer Med
; 10(4): 1314-1326, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33492774
5.
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
J Clin Oncol
; 25(1): 16-24, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17194902
Resultados
1 -
5
de 5
1
Próxima >
>>